Clinical Trial Update: Gemcitabine, Oxaliplatin, Tarceva &/or Cisplatin in HCC & Biliary Tree Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating gemcitabine, oxaliplatin, Tarceva (erlotinib) and/or cisplatin in hepatocellular carcinoma and biliary tract cancers was terminated wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer
• Hepatocellular Carcinoma
• Periampullary Adenocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)
• OXALIPLATIN (Oxaliplatin)
• Tarceva (erlotinib)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Hepatocellular Carcinoma, Cholangiocellular Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2015-07-14